How much is COVID-19 vaccine worth? $2bn per 100m doses
US government agrees a deal for 100m doses of potential vaccine, with option to take further 500m order.
Archives for July 22, 2020
The growth of the UK’s ‘golden triangle’
Research outlines the pace of growth in the UK’s biohub and how it will progress towards 2050.
MaxCyte partners with Apeiron for siRNA immunotherapy
MaxCyte and Apeiron enter agreement for the use of engineering equipment for the development of a cell therapy.
Ireland calls attention to cell and gene infrastructure
A report by IDA outlines investment made by biopharma into cell and gene development and manufacturing capabilities.
MassBio wants improved manufacturing to maintain biohub position
The organization calls for capabilities to manufacture advanced therapeutics, such as cell and gene therapies.